GastroEsophageal Cancer New Reference: Pembrolizumab with Chemotherapy in Advanced Gastric Cancer Ulas D. Bayraktar, MD 2023-11-20
GastroEsophageal Cancer New Reference: Trastuzumab Deruxtecan in her2-Positive Advanced Gastroesophageal Cancer Ulas D. Bayraktar, MD 2023-08-20
GastroEsophageal Cancer New Protocol: Trastuzumab, Ramucirumab, and PACLitaxel for her2-Positive Advanced Gastroesophageal Cancer Ulas D. Bayraktar, MD 2023-06-24
GastroEsophageal Cancer New Protocol: First-line regorafenib with nivolumab and chemotherapy in advanced esophageal, gastric, or gastro-esophageal junction cancer Ulas D. Bayraktar, MD 2023-06-07
GastroEsophageal Cancer New Protocol: Perioperative FLOT with Trastuzumab and Pertuzumab for her2-Positive Gastroesophageal Cancer Ulas D. Bayraktar, MD 2022-07-16
